These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 33593235)

  • 1. Direct medical costs of non-alcoholic fatty liver disease in Catalonia at the hospital level: a retrospective multicenter study.
    Darbà J
    Expert Rev Pharmacoecon Outcomes Res; 2022 Mar; 22(2):341-349. PubMed ID: 33593235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Healthcare resource utilization and costs of nonalcoholic steatohepatitis patients with advanced liver disease in Italy.
    Petta S; Ting J; Saragoni S; Degli Esposti L; Shreay S; Petroni ML; Marchesini G;
    Nutr Metab Cardiovasc Dis; 2020 Jun; 30(6):1014-1022. PubMed ID: 32423665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comorbidities and healthcare costs and resource use of patients with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) in the Japan medical data vision database.
    Terai S; Buchanan-Hughes A; Ng A; Lee IH; Hasegawa K
    J Gastroenterol; 2021 Mar; 56(3):274-284. PubMed ID: 33496858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease severity predicts higher healthcare costs among hospitalized nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) patients in Spain.
    Romero-Gomez M; Kachru N; Zamorano MA; Darba J; Shreay S
    Medicine (Baltimore); 2020 Dec; 99(50):e23506. PubMed ID: 33327291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease Severity Is Associated With Higher Healthcare Utilization in Nonalcoholic Steatohepatitis Medicare Patients.
    C Gordon S; Fraysse J; Li S; Ozbay AB; Wong RJ
    Am J Gastroenterol; 2020 Apr; 115(4):562-574. PubMed ID: 31833859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rising Inpatient Encounters and Economic Burden for Patients with Nonalcoholic Fatty Liver Disease in the USA.
    Nguyen AL; Park H; Nguyen P; Sheen E; Kim YA; Nguyen MH
    Dig Dis Sci; 2019 Mar; 64(3):698-707. PubMed ID: 30327963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic Fatty Liver Disease 2020: The State of the Disease.
    Cotter TG; Rinella M
    Gastroenterology; 2020 May; 158(7):1851-1864. PubMed ID: 32061595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthcare resource utilization and costs of care in the United States for patients with non-alcoholic steatohepatitis.
    Tapper EB; Bonafede M; Fishman J; Dodge S; Miller K; Zeng N; Lewandowski D; Bogdanov A
    J Med Econ; 2023; 26(1):348-356. PubMed ID: 36866575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.
    Perumpail BJ; Khan MA; Yoo ER; Cholankeril G; Kim D; Ahmed A
    World J Gastroenterol; 2017 Dec; 23(47):8263-8276. PubMed ID: 29307986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient characteristics and hospitalisation costs of spinal muscular atrophy in Spain: a retrospective multicentre database analysis.
    Darbà J; Marsà A
    BMJ Open; 2019 Nov; 9(11):e031271. PubMed ID: 31753879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health Care Costs of Patients With Biopsy-Confirmed Nonalcoholic Fatty Liver Disease Are Nearly Twice Those of Matched Controls.
    Hagström H; Nasr P; Ekstedt M; Hammar U; Widman L; Stål P; Hultcrantz R; Kechagias S; Henriksson M
    Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1592-1599.e8. PubMed ID: 31634581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience.
    Perumpail RB; Wong RJ; Ahmed A; Harrison SA
    Dig Dis Sci; 2015 Oct; 60(10):3142-8. PubMed ID: 26250831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe.
    Younossi ZM; Blissett D; Blissett R; Henry L; Stepanova M; Younossi Y; Racila A; Hunt S; Beckerman R
    Hepatology; 2016 Nov; 64(5):1577-1586. PubMed ID: 27543837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modern approach to the clinical management of non-alcoholic fatty liver disease.
    Del Ben M; Polimeni L; Baratta F; Pastori D; Loffredo L; Angelico F
    World J Gastroenterol; 2014 Jul; 20(26):8341-50. PubMed ID: 25024593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic impact of patients admitted to stroke units in Spain.
    Alvarez-Sabín J; Quintana M; Masjuan J; Oliva-Moreno J; Mar J; Gonzalez-Rojas N; Becerra V; Torres C; Yebenes M;
    Eur J Health Econ; 2017 May; 18(4):449-458. PubMed ID: 27084749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in outpatient resource utilizations and outcomes for Medicare beneficiaries with nonalcoholic fatty liver disease.
    Younossi ZM; Zheng L; Stepanova M; Henry L; Venkatesan C; Mishra A
    J Clin Gastroenterol; 2015 Mar; 49(3):222-7. PubMed ID: 24637730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and Economic Burden of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.
    Younossi ZM; Henry L; Bush H; Mishra A
    Clin Liver Dis; 2018 Feb; 22(1):1-10. PubMed ID: 29128049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospital care and medical costs of septic arthritis in Spain: a retrospective multicenter analysis.
    Darbà J; Marsà A
    J Med Econ; 2022; 25(1):381-385. PubMed ID: 35236216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic fatty liver disease: impact on healthcare resource utilization, liver transplantation and mortality in a large, integrated healthcare system.
    Cotter TG; Dong L; Holmen J; Gilroy R; Krong J; Charlton M
    J Gastroenterol; 2020 Jul; 55(7):722-730. PubMed ID: 32328797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-alcoholic fatty liver disease patients attending two metropolitan hospitals in Melbourne, Australia: high risk status and low prevalence.
    George ES; Roberts SK; Nicoll AJ; Reddy A; Paris T; Itsiopoulos C; Tierney AC
    Intern Med J; 2018 Nov; 48(11):1369-1376. PubMed ID: 29845719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.